Cervical cancer screening overuse and underuse: Patient and physician factors

American Journal of Managed Care

Volumn 19, Issue 6, 2013, Pages 482-489

  Almeida, Cristina M ^a   Rodriguez, Michael A ^a   Skootsky, Samuel ^a   Pregler, Janet ^a   Steers, Neil ^a   Wenger, Neil S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CANCER PATIENT; CANCER RISK; CANCER SCREENING; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

ADULT; AGED; AGED, 80 AND OVER; DATABASES, FACTUAL; FEMALE; HEALTH SERVICES MISUSE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; PAPANICOLAOU TEST; PHYSICIAN'S PRACTICE PATTERNS; UNITED STATES; UTERINE CERVICAL NEOPLASMS;

EID: 84880460123     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. ACOG Committee on Practice Bulletins. ACOG Practice Bulletin: clinical management guidelines for obstetriciangynecologists. Number 45, August 2003. Cervical cytology screening. Obstet Gynecol. 2003;102(2):417-427.
2. Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin. 2002;52(6):342-362.
3. US Preventive Services Task Force. Screening for cervical cancer: recommendations and rationale. AHRQ Publication No. 03-515A. Rockville, MD: Agency for Healthcare Research and Quality; 2003.
4. Sawaya GF, McConnell KJ, Kulasingam SL, et al. Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. N Engl J Med. 2003;349(16):1501-1509.
5. Sasieni P, Adams J, Cuzick J. Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer. 2003;89(1):88-93.
6. IARC Working Group on evaluation of cervical cancer screening programs. Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. Br Med J (Clin Res Ed). 1986;293(6548):659-664.
7. Eddy DM. The frequency of cervical cancer screening: comparison of a mathematical model with empirical data. Cancer. 1987;60(5): 1117-1122.
8. Sherman ME, Lorinez AT, Scott DR, et al. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. J Natl Cancer Inst. 2003;95(1):46-52.
9. Van Oortmarssen GJ, Habbema JDF, van Ballegooijen M. Predicting mortality from cervical cancer after negative smear test results. BMJ. 1992;305(6851):449-451.
10. Screening for Cervical Cancer: Systematic Evidence Review Number 25. January 2003. US Preventive Services Task Force. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/clinic/uspstf/uspscerv.htm. Accessed July 24, 2009.
11. Sawaya GF, Kerlikowske K, Lee NC, Gildengorin G, Washington AE. Frequency of cervical smear abnormalities within 3 years of normal cytology. Obstet Gynecol. 2000;96(2):219-223.
12. Cooper CP, Saraiya M, McLean TA, et al. Report from the CDC. Pap test intervals used by physicians serving low-income women through the National Breast and Cervical Cancer Early Detection Program. J Womens Health (Larchmt). 2005;4(8):670-678.
13. Saint M, Gildengorin G, Sawaya GF. Current cervical neoplasia screening practices of obstetrician/gynecologists in the US. Am J Obstet Gynecol. 2005;192(2):414-421.
14. Anon. ACOG committee opinion No. 431: routine pelvic examination and cervical cytology screening. Obstet Gynecol. 2009;113(5):1190-1193.
15. Moyer VA on behalf of the US Preventive Services Task Force. Screening for cervical cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;156(12):880-891. W312.
16. Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol. 2012;137(4):516-542.
17. Saraiya M, McCaig LF, Ekwueme DU. Ambulatory care visits for Pap tests, abnormal Pap test results, and cervical cancer procedures in the United States. Am J Manag Care. 2010;16(6):e137-e144.
18. US Preventive Services Task Force. Screening for Cervical Cancer, Topic Page. http://www.uspreventiveservicestaskforce.org/uspstf/uspscerv.htm. Published April 2012. Accessed August 11, 2012.
19. American Congress of Obstetricians and Gynecologists. New Cervical Cancer Screening Recommendations from the U.S. reventive ServicesTask Force and the American Cancer Society/American Society for Colposcopy and Cervical Pathology/American Society for Clinical Pathology. www.acog.org/About-ACOG/ Announcements/New-Cervical-Cancer-Screening-Recommendations. Accessed August 11, 2012.
20. Solomon D, Breen N, McNeel T. Cervical cancer screening rates in the United States and the potential impact of implementation of screening guidelines. CA Cancer J Clin. 2007;57(2):105-111.
21. Meissner HI, Tiro JA, Haggstrom D, Lu-Yao G, Breen N. Does patient health and hysterectomy status influence cervical cancer screeningin older women? J Gen Intern Med. 2008;23(11):1822-1828.
22. Meissner HI, Tiro JA, Yabroff KR, Haggstrom DA, Coughlin SS. Too much of a good thing? physician practices and patient illingness for less frequent pap test screening intervals. Med Care. 2010;48(3): 249-259.
23. Yabroff KR, Saraiya M, Meissner HI, et al. Specialty differences in primary care physician reports of papanicolaou test creening practices:a national survey, 2006 to 2007. Ann Intern Med. 2009;151(9): 602-611.
24. Saraiya M, Berkowitz Z, Yabroff KR, Wideroff L, Kobrin S, Benard V. Cervical cancer screening with both human apillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending? Arch Intern Med. 2010;170(11):977-985.
25. Blackwell DL, Martinez ME, Gentleman JF. Women's compliance with public health guidelines for mammograms and pap tests inCanada and the United States: an analysis of data from the Joint Canada/United States Survey of Health. Womens Health Issues. 2008; 18(2):85-99.
26. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? a framework for improvement. JAMA. 1999;282(15):1458-1465.
27. Qaseem A, Alguire P, Dallas P, et al. Appropriate use of screeningand diagnostic tests to foster high-value, costconscious care. AnnIntern Med. 2012;156(2):147-149.
28. Anon. The "top 5" lists in primary care: meeting the responsibility of professionalism. Arch Intern Med. 2011;171(15):1385-1390.
29. Armstrong D. Clinical autonomy, individual and collective: the problem of changing doctors' behaviour. Soc Sci Med. 2002;55(10):1771-1777.
30. Kravitz RL, Bell RA, Azari R, Kelly-Reif S, Krupat E, Thom DH. Direct observation of requests for clinical services in office practice: what do patients want and do they get it? Arch Intern Med. 2003;163(14): 1673-1681.
31. Haggerty J, Tudiver F, Brown JB, Herbert C, Ciampi A, Guibert R. Patients' anxiety and expectations: how they influence family physicians' decisions to order cancer screening tests. Can Fam Physician. 2005;51:1658-1659.